Res. Asst. OSMAN SÜTCÜOĞLU

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)

AKYILDIZ A., GÜVEN D. C., KÖKSAL B., KARAOĞLAN B. B., Kivrak D., Ismayilov R., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9, pp.4991-4999, 2024 (SCI-Expanded)

A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

GÜRLER F., Tay F., Sucuoğlu İşleyen Z., Yerlikaya T., Hendem E., Esen S. A., et al.

Cancer Medicine , vol.13, no.14, 2024 (SCI-Expanded)

Effect of PRMT1 and ZEB1 expression on first-line FOLFIRINOX chemotherapy response in patients with locally advanced or metastatic pancreatic cancer

Coskun Gencalp C., Sutcuoglu O., Ogut B., Ozdemir N.

ANNALS OF ONCOLOGY , 2024 (SCI-Expanded)

Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors

Yücel K. B., AYDOS U., SÜTCÜOĞLU O., Kılıç A. C. K., ÖZDEMİR N., ÖZET A., et al.

Cancer Chemotherapy and Pharmacology , vol.93, no.5, pp.497-507, 2024 (SCI-Expanded)

Niraparib-induced pure red cell aplasia

BİR YÜCEL K., YILDIZ Ş., SÜTCÜOĞLU O., Güvercin F. S., UYAR GÖÇÜN F. P., ÖZDEMİR N., et al.

Journal of Oncology Pharmacy Practice , vol.30, no.1, pp.210-214, 2024 (SCI-Expanded)

Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy.

BİR YÜCEL K., Kilic A. C., SÜTCÜOĞLU O., YAZICI O., Kilic K., SAVAŞ G., et al.

Journal of chemotherapy (Florence, Italy) , vol.36, no.3, pp.249-257, 2024 (SCI-Expanded)

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer

AKDOĞAN O., SÜTCÜOĞLU O., ÖZET A., YAZICI O., ÖZDEMİR N.

Supportive Care in Cancer , vol.31, no.8, 2023 (SCI-Expanded)

Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer

Şener G. Y., SÜTCÜOĞLU O., ÖĞÜT B., Güven D. C., Kavuncuoğlu A., ÖZDEMİR N., et al.

Strahlentherapie und Onkologie , vol.199, no.8, pp.761-772, 2023 (SCI-Expanded)

Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

SÜTCÜOĞLU O., Doğan A., Yilmaz F., Şahin A. B., Şahin T. K., Esen S. A., et al.

Pancreas , vol.52, no.4, 2023 (SCI-Expanded)

Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment

BİR YÜCEL K., SÜTCÜOĞLU O., YAZICI O., YILDIZ Y., ŞENOL E., ÜNER A.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.3, pp.760-763, 2023 (SCI-Expanded)

Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Yücel K. B., Özay Z. I., SÜTCÜOĞLU O., YAZICI O., ÜNER A., GÜNEL N., et al.

Supportive Care in Cancer , vol.31, no.2, 2023 (SCI-Expanded) Sustainable Development

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

SÜTCÜOĞLU O., Rustamova Cennet N., ÖZET A., ÖZDEMİR N., YAZICI O.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology , vol.41, no.2, pp.416-417, 2023 (SCI-Expanded)

The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective

SÜTCÜOĞLU O., ERDAL Z. S., Akdoğan O., ÇELTİKÇİ E., ÖZDEMİR N., ÖZET A., et al.

Turkish Journal of Medical Sciences , vol.53, no.1, pp.420-431, 2023 (SCI-Expanded)

Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study

Almuradova E., Basoglu T., Nayir E., Bayram E., PAYDAŞ S., Gokmen I., et al.

NEOPLASMA , vol.70, no.1, pp.158-165, 2023 (SCI-Expanded)

Renal Clear Cell Carcinoma with Unknown Primary: Is It Real Entity or Just Hypothesis?

BÖRÜ Y. E., SÜTCÜOĞLU O., ÇALIŞKAN GÜNEŞ K., UYAR GÖÇÜN F. P., YAZICI O.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN , vol.32, pp.200-202, 2022 (SCI-Expanded) Sustainable Development

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Sütcüoğlu O., Özet A., Yazıcı O., Özdemir N.

Journal of Clinical Oncology , vol.40, no.34, pp.4027, 2022 (SCI-Expanded)

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

KILIÇ B., SÜTCÜOĞLU O., YAZICI O., ÖZDEMİR N.

JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.33, 2022 (SCI-Expanded)

Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma

Aslan V., Kılıç A. C., Sütcüoğlu O., Eraslan E., Bayrak A., Öksüzoğlu B., et al.

Urologic Oncology: Seminars and Original Investigations , vol.40, no.11, 2022 (SCI-Expanded) Sustainable Development

Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma

SÜTCÜOĞLU O., ÖZET A., YAZICI O., ÖZDEMİR N.

LANCET ONCOLOGY , vol.23, no.10, 2022 (SCI-Expanded)

Current status of biosimilars in Turkey: A survey among medical oncologists

Gürler F., Kasım D. D., Kurt İnci B., Sütçüoğlu O., Ünsal O., Aslan V., et al.

Journal of Oncology Pharmacy Practice , vol.28, no.7, pp.1516-1523, 2022 (SCI-Expanded)

Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer

AKDOĞAN O., Sutcuoglu O., Ogut B., Akyurek N., Ozdemir N., Ozet A., et al.

IMMUNOTHERAPY , vol.14, no.14, pp.1121-1131, 2022 (SCI-Expanded) Sustainable Development

How molecularly similar are primary and metastatic tissues in renal cell carcinoma?

KILIÇ B., SÜTCÜOĞLU O., ÖZDEMİR N., YAZICI O.

LANCET ONCOLOGY , vol.23, no.7, 2022 (SCI-Expanded)

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

ASLAN V., SÜTCÜOĞLU O., ÖZET A., ÖZDEMİR N., YAZICI O.

JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.19, pp.2177-2179, 2022 (SCI-Expanded)

A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma

DEMİR E., SÜTCÜOĞLU O., DEMİR B., ÜNSAL O., YAZICI O.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, pp.445-448, 2022 (SCI-Expanded) Sustainable Development

ROAR trial: which treatment is effective after progression?

SÜTCÜOĞLU O., Yücel K., ÜNER A., YAZICI O., ÖZDEMİR N.

LANCET ONCOLOGY , vol.23, no.3, 2022 (SCI-Expanded)

Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?

Sütcüoğlu O., Ulaş Kahya B., Özdemir N., Yazıcı O.

Journal Of Clinical Oncology , vol.0, no.0, pp.12-13, 2022 (SCI-Expanded) Sustainable Development

Role of silymarin (<i>Silybum marianum</i>) in the prevention of colistin-induced acute nephrotoxicity in rats.

Dumludag B., Derici M. K., Sütcüoğlu O., Ogut B., Paşaoğlu Ö. T., Işık Gönül İ., et al.

Drug and chemical toxicology , vol.45, no.2, pp.568-575, 2022 (SCI-Expanded)

Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis

ÜNSAL O., SÜTCÜOĞLU O., YAZICI O.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, pp.486-488, 2022 (SCI-Expanded)

Bone marrow involvement in breast cancer

SÜTCÜOĞLU O., ÖZDEMİR N., YAZICI O., ÖZET A.

CURRENT PROBLEMS IN CANCER , vol.46, no.1, 2022 (SCI-Expanded) Sustainable Development

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Gürler F., İlhan A., Güven D. C., Turhan O., Kurt İnci B., Sütçüoğlu O., et al.

Anti-Cancer Drugs , vol.33, no.1, pp.477-485, 2022 (SCI-Expanded) Sustainable Development

Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients

BİR YÜCEL K., Kilic A. C., SÜTCÜOĞLU O., YAZICI O., AYDOS U., Kilic K., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , vol.75, pp.368-375, 2022 (SCI-Expanded) Sustainable Development

"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor"

Albayrak H. C., Gürler F., Sütçüoğlu O., Akyürek N., Özet A.

Anti-Cancer Drugs , vol.33, no.1, pp.109-111, 2022 (SCI-Expanded)

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma

Gürler F., Güven D. C., Aydemir E., Sütcüoğlu O., Kurt İnci B., Arık Z., et al.

Turkish Journal of Medical Sciences , vol.52, no.5, pp.1559-1568, 2022 (SCI-Expanded)

Metastatic colorectal cancer in both sides of Aegean sea: practice patterns and outcome

YAZICI O., Ucar G., SÜTCÜOĞLU O., Turhal N. S., Yildiz B., Karamouzis M., et al.

CURRENT MEDICAL RESEARCH AND OPINION , vol.38, no.4, pp.579-586, 2022 (SCI-Expanded) Sustainable Development

Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Sütcüoğlu O., Yazıcı O., Özet A.

Future oncology (London, England) , vol.17, pp.4823-4825, 2021 (SCI-Expanded)

Panitumumab-induced trichomegaly.

Sütcüoğlu O., Özet A.

Current problems in cancer , vol.45, 2021 (SCI-Expanded)

Brigatinib-induced tuberculosis reactivation: A case report

KEŞ V., SÜTCÜOĞLU O., GÜRLER F., YAZICI O., ÖZET A.

Current Problems in Cancer , vol.45, 2021 (SCI-Expanded) Sustainable Development

Thirty-day mortality rates after immunotherapy initiation.

Sütcüoğlu O., İlhan A., Tacar S. Y., Güven D. C., Uçar G., Karadurmuş N., et al.

Immunotherapy , vol.13, pp.1419-1426, 2021 (SCI-Expanded)

Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

Karacin C., Eren T., Zeynelgil E., Imamoglu G. I., Altinbas M., Karadag I., et al.

FUTURE ONCOLOGY , vol.17, no.33, pp.4447-4456, 2021 (SCI-Expanded) Sustainable Development

Re: Post-progression outcomes of NSCLC patients with PD-L1 expression >= 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

SÜTCÜOĞLU O., ÖZDEMİR N., YAZICI O.

EUROPEAN JOURNAL OF CANCER , vol.155, pp.294-295, 2021 (SCI-Expanded)

The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia

SÜTCÜOĞLU O., AKDOĞAN O., GÜRLER F., KURT İNCİ B., ÖZDEMİR N., ÖZET A., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.7, 2021 (SCI-Expanded) Sustainable Development

Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality

Sütcüoğlu O., Akdogan O., Kurt İnci B., Gurler F., Ozdemir N., Yazıcı O.

SUPPORTIVE CARE IN CANCER , vol.29, no.2, pp.1047-1053, 2021 (SCI-Expanded) Sustainable Development

Harmful consequences of COVID-19 fear in patients with cancer.

Sutcuoglu O., Yazici O., Ozet A., Ozdemir N.

BMJ supportive & palliative care , 2020 (SCI-Expanded) Sustainable Development

Herpes zoster infection of the breast

SÜTCÜOĞLU O., Ozdemir N.

BREAST JOURNAL , vol.26, no.11, pp.2267-2268, 2020 (SCI-Expanded)

Is it possible to prevent contrast-induced nephropathy with dexpanthenol?

SÜTCÜOĞLU O., DERİCİ M. K., PAŞAOĞLU Ö. T., Dumludag B., Helvaci Ö., Ogut B., et al.

International urology and nephrology , vol.51, no.8, pp.1387-1394, 2019 (SCI-Expanded)

Primary renal neuroendocrine carcinoma: Diagnosis and treatment dilemmas

Ciltas A., SÜTCÜOĞLU O., Civelek R., Benekli M.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.6, pp.1444-1445, 2018 (SCI-Expanded)

Articles Published in Other Journals

Can artificial intelligence provide accurate and reliable answers to cancer patients’ questions about cancer pain? Comparison of chatbots based on ESMO cancer pain guideline

BİR YÜCEL K., Sutcuoglu O., YAZICI O., ÖZET A., ÖZDEMİR N.

Memo - Magazine of European Medical Oncology , 2024 (ESCI)

Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer

Yücel K. B., SÜTCÜOĞLU O., YAZICI O., ÖZET A., ÖZDEMİR N.

Journal of Gastrointestinal Cancer , vol.54, no.4, pp.1268-1275, 2023 (ESCI) Sustainable Development

Tam Kan Sayımı Parametreleri ile İleri Evre Mide Kanseri Olan Hastaların Prognozunu Tahmin Edilebilir Mi?

Sütcüoğlu O., Fincan A., Gürler F., İnci B. K., Özdemir N., Yazıcı O.

Turkish Journal of Clinics and Laboratory , vol.14, no.2, pp.243-245, 2023 (Peer-Reviewed Journal)

An Immature Ovarian Teratoma with Glioblastoma Multiforme and Gliomatosis Peritonei

Tuzcu B., Sütcüoğlu O., CANSIZ ERSÖZ C., ÖZDEMİR N.

Indian Journal of Gynecologic Oncology , vol.21, no.2, 2023 (Scopus)

Krukenberg Tumor Presentation of Recurrent Gallbladder Cancer After a Decade

Tuzcu B., SÜTCÜOĞLU O., KOLAY BAYRAM E., Erdem O., YAZICI O.

JOURNAL OF GASTROINTESTINAL CANCER , vol.54, no.1, pp.264-267, 2023 (ESCI) Sustainable Development

A Case of Burned-out Testicular Germ Cell Tumor Diagnosed Eleven Years Later On Bir Yıl Sonra Teşhis Edilen Spontan Regrese Olmuş Testis Germ Hücreli Tümör Olgusu

AYDEMİR E., SÜTCÜOĞLU O., Gönül İ. I., ONARAN M., YAZICI O.

Gazi Medical Journal , vol.34, no.4, pp.443-445, 2023 (ESCI)

Association of Immunoscore, CD73 Expression and 53BP1 Expression with Neoadjuvant Chemoradiotherapy Efficacy in Patients with Locally Advanced Rectal Cancer

Sütcüoğlu O., İnan M. A., Üner A., Savaş G., Bora H., Özet A., et al.

Journal of oncological sciences , vol.9, no.1, pp.23-32, 2023 (Scopus)

Prognostic Importance of the Lymph Node Ratio in Stage III Colorectal Cancers

ERDOĞAN K., Yılmaz N., Erdoğan A., SÜTCÜOĞLU O., YAZICI O., ÖZDEMİR N.

Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , vol.29, pp.661-670, 2022 (Peer-Reviewed Journal)

Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis

Kuş T., Yildirim Özdemir N., Aktaş G., SÜTCÜOĞLU O., Yalçintaş Arslan Ü., Dirikoç M., et al.

Journal of Oncological Science , vol.8, no.3, pp.127-134, 2022 (Scopus)

Review of Immunotherapy Efficacy in Virus-associated Cancers

Ozay Z. I., SÜTCÜOĞLU O., ÖZDEMİR N., YAZICI O.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.6, no.2, pp.100-110, 2022 (ESCI) Sustainable Development

Pancreatic metastasis of invasive ductal breast carcinoma: A potential diagnostic pitfall.

Geneş Z. K., Esendağlı G., Sütcüoğlu O., Şimşek B., Özet A.

Breast disease , vol.41, no.1, pp.187-189, 2022 (Scopus)

Chylous acid that develops after COVID-19 infection in a patient with ovarian cancer Over Kanserli Bir Hastada COVID-19 Enfeksiyonu Sonrası Gelişen Şilöz Asit

SEZER B., SÜTCÜOĞLU O., ÖZDEMİR N.

Gazi Medical Journal , vol.32, no.4, pp.593-595, 2021 (ESCI) Sustainable Development

A Single Center Treatment Experience in Autoimmune Hepatitis Patients

SÜTCÜOĞLU O., Sargin Z. G., Haghighi N. A., Yuceldi S. D., Karatas A., Onal I. K., et al.

GAZI MEDICAL JOURNAL , vol.28, no.3, pp.174-178, 2017 (ESCI)

Refereed Congress / Symposium Publications in Proceedings

The ability of the LACE index to predict 30-day readmissions in oncology patients

ULAŞ KAHYA B., YAZICI O., Sutcuoglu O., ÖZDEMİR N., Gunel N., ÜNER A., et al.

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023

Evaluation of the quality and reliability of ChatGPT and Perplexity′s responses about rectal cancer

YAZICI O., BİR YÜCEL K., Sutcuoglu O.

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023

BAŞ VE BOYUN KANSERLERINDE (KEMO) RADYOTERAPI SONRASI PRIMER VE REKÜRREN/ REFRAKTER DOKUDA PD-L1 VE VISTA EKSPRESYON DURUMUNUN KARŞILAŞTIRILMASI

YAZICI ŞENER G., SÜTCÜOĞLU O., ÖĞÜT B., GÜVEN D. C., KAVUNCUOĞLU A., ÖZDEMİR N., et al.

9. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 18 May 2022 Sustainable Development

SERUM ÜRİK ASİT SEVİYESİNİN YOĞUN BAKIM MORTALİTESİ İLE İLİŞKİSİ

Sütcüoğlu O., Aygencel Bıkmaz Ş. G., Türkoğlu M.

3. Eskisehir Onkoloji Gunleri, Eskişehir, Turkey, 11 - 13 March 2022, vol.1, no.10, pp.30-31

Erken Evre Mide Kanserinde Cerrahi İle Adjuvan Kemoterapi Arasında Geçen Sürenin Prognoza Etkisi

Bir Yücel K., Sütcüoğlu O., Özdemir N., Yazıcı O.

3. Eskisehir Onkoloji Gunler,, Eskişehir, Turkey, 11 - 13 March 2022, vol.1, no.18, pp.146 Sustainable Development

EVRE III KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERLERİNDE NEOADJUVAN KEMOTERAPİ/KEMORADYOTERAPİNİN TÜMÖR DOKUSUNDA PD-L1 VE VİSTA EKSPRESYON DÜZEYİNE ETKİSİ

Akdoğan O., Sütcüoğlu O., Öğüt B., Akyürek N., Özdemir N., Özet A., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 4 - 06 November 2021 Sustainable Development

BEYİN MAGNETİK REZONANS GÖRÜNTÜLEMEDE TEMPORAL KAS ALANI ÖLÇÜMÜNÜN GLİOBLASTOME MULTİFORME PROGNOZU İLE İLİŞKİSİ

Sütcüoğlu O., Akdoğan O., Erdal Z. S., Özdemir N., Özet A., Uçar M., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 04 November 2021

ON BİR YIL SONRA TEŞHİS EDİLEN SPONTAN REGRESE OLMUŞ GERM HÜCRELİ TÜMÖR OLGUSU

AYDEMİR E., SÜTCÜOĞLU O., IŞIK GÖNÜL İ., ONARAN M., YAZICI O.

8. Türk Tıbbi Onkoloji Kongresi, Turkey, 03 November 2021

SİSTEMİK ANTİ-HER2 TEDAVİSİ BÜYÜK EKLEM OSTEONEKROZLARINDAN SORUMLU OLABİLİR Mİ?

Altınbezer A., Sütcüoğlu O., Ataoğlu M. B., Yazıcı O.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

İNVAZİV DUKTAL MEME KARSİNOMUNUN PANKREAS METASTAZI: OLAĞANDIŞI TANISAL TUZAKLARI OLAN BİR OLGU

Küçükoğlu Z., Esendağlı G., Sütcüoğlu O., Şimşek B., Yazıcı O.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

KASTRASYONA DİRENÇLİ PROSTAT KANSERİNDE VÜCUT KİTLE İNDEKSİNİN YENİ ANTİ-ANDROJEN TEDAVİLERİNİN TEDAVİ SONUÇLARINA ETKİSİ

Sütcüoğlu O., Yazıcı O., Özdemir N., Üner A., Özet A.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021 Sustainable Development

TIBBİ ONKOLOJI SERVİS YATIŞ SÜRESİNİ ÖNGÖRMEDE HEMOGLOBİN, ALBÜMİN, LENFOSİT VE TROMBOSİT KOMBİNASYONUNUN DEĞERİ

Sütcüoğlu O., Ünsal O., Aslan V., Ulaş Kahya B., Tahtacı G., Özdemir N., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

SARKOPENİ VE OBEZİTENİN METASTATİK RCC HASTALARINDA İMMÜNOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİ ÖNGÖRMEDEKİ ROLÜ,

Aslan V., Sütcüoğlu O., Ünsal O., Yazıcı O., Özdemir N., Üner A., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

İLERİ EVRE PANKREAS KANSERİNDE FOLFIRİNOX BAŞARISIZLIĞI SONRASI GEMSİTABİNE BAZLI TEDAVİLERİN ETKİNLİĞİ

Sütcüoğlu O., Yılamz F., Aktürk Esen S., Erol C., Eraslan E., Üner A., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021 Sustainable Development

EVRE III KOLOREKTAL KANSERLERDE LENF NODU POZİTİFLİK ORANININ PROGNOSTİK ÖNEMİ

Erdoğan K., Yılmaz N., Sütcüoğlu O., Yazıcı O., Erdoğan A., Özdemir N.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021 Sustainable Development

ALFA-FETOPROTEİN ÜRETEN PRİMER AKCİĞER ADENOKARSİNOM OLGUSU

Ercan Uzundal D., Sütcüoğlu O., Yazıcı O., Özdemir N.

8. Türk Tıbbi Onkoloji Kongresi, 03 November 2021

“The Value of Hemoglobin, Albumin, Lymphocyte and Thrombocyte Combination in Predicting Length Of Stay in the Oncology Service”

Sütcüoğlu O., Özdemir N., Özet A., Yazıcı O.

MEDICRES | 2021 8TH INTERNATIONAL MULTIDISCIPLINARY CONGRESS ON GOOD MEDICAL RESEARCH CONFERENCE, 25 - 28 October 2021

İMMÜNOTERAPİ SONRASI İLK 30 GÜNLÜK MORTALİTE ORANI

Sütcüoğlu O., Ilhan A., Tacar S. Y., Güven D. C., Uçar G., Karadurmuş N., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021

Comparison of PD L1 and VISTA Expression Levels in Head and Neck Cancers in Primary and Recurrent Tumor Tissue after Radiotherapy / Chemoradiotherapy

Yazıcı Şener G., Sütcüoğlu O., Öğüt B., Güven D. C., Kavuncuoğlu A., Özdemir N., et al.

ESmo Virtual Congress 21, 16 September 2021 Sustainable Development

The Effect of Neoadjuvant Chemotherapy / Chemoradiotherapy on Tumor Tissue PD-L1 And VISTA Expression Levels in Non-Small Cell Lung Cancers (NSCLC)

Akdoğan O., Sütcüoğlu O., Öğüt B., Akyürek N., Özdemir N., Özet A.

Esmo Virtual Congress 21, 16 September 2021 Sustainable Development

Retrospective Analysis of Co inhibitor and Co stimulator Immune Pathways in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

Gürler F., Aktürk Esen S., Kurt İnci B., Sütcüoğlu O., Uçar G., Uncu D., et al.

ESmo Virtual Congress 21, 16 September 2021

THE EFFECT OF THE TIME FROM THE DATE OFPATHOLOGICAL DIAGNOSIS TO THE STARTOF CHEMOTHERAPY IN GASTRIC CANCERPROGNOSIS

SÜTCÜOĞLU O., YAZICI O., ÖZET A., ÖZDEMİR N.

10. IGICC, 2 - 06 December 2020 Sustainable Development

IS MORE INTENSIVE CHEMOTHERAPYREASONABLE IN GASTRIC CANCER PATIENTSWITH PERITONEAL METASTASIS? AMULTICENTER STUDY

KUŞ T., ÖZDEMİR N., AKTAŞ G., SÜTCÜOĞLU O., YALÇINTAŞ ARSLAN Ü., dirikoc m., et al.

10.IGICC, 2 - 06 December 2020 Sustainable Development

Session XI: Polipozis and Nonpolipozis CRC-Discussants

SÜTCÜOĞLU O.

10.IGICC, 04 December 2020

NÖTROPENİK ATEŞ İLEBAŞVURAN HASTADAGÜNCEL RİSK İNDEKSLERİYETERLİ Mİ?

SÜTCÜOĞLU O., AKDOĞAN O., GÜRLER F., KURT İNCİ B., ÖZDEMİR N., YAZICI O.

TTOD Sanal Kongresi, Turkey, 12 - 15 November 2020

PARANEOPLASTİK POLİNÖROPATİ KLİNİĞİ İLEBAŞVURAN EXTRAGONADAL GERM HÜCRELİ TÜMÖROLGUSU.

ASLAN V., ÜNSAL O., RUSTEMOVA N., SÜTCÜOĞLU O., KURT İNCİ B., GÜRLER F., et al.

TTOD SANAL KONGRESİ, Turkey, 12 - 15 November 2020

YENİ BİR TEDAVİ MODELİ: İLERİ EVRE AKCİĞERADENOKARSİNOMLU BİR OLGUDA NİVOLUMABTEDAVİSİNİN ARALIKLI KULLANIMI

ÜNSAL O., ASLAN V., RÜSTEMOVA N., SÜTCÜOĞLU O., KURT İNCİ B., GÜRLER F., et al.

TTOD SANAL KONGRESİ, Turkey, 12 - 15 November 2020

FP683BELIEFS AND ATTITUDES OF HEMODIALYSIS PATIENTS ON INFLUENZA VACCINATION

HELVACI Ö., SUTCUOGLU O., KORUCU B., DİZBAY M., ARINSOY S. T., DERİCİ Ü.

55th ERA-EDTA congress, Kopenhag, Denmark, 24 - 27 May 2018, vol.33, pp.276

Malign hipertansiyona bağlı gelişen trombotik mikroanjiopati tedavisinde eculizumabın rolü

ÖZBAŞ B., ÇATALTEPE E., KORUCU B., HASAN HACI Y., HELVACI Ö., SÜTÇÜOĞLU O., et al.

Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, Turkey, 9 - 13 May 2018

Radyokontrast nefrotoksisitesi dexpantenol ile önlenebilir mi?

SUTCUOGLU O., DERİCİ M. K., PAŞAOĞLU Ö. T., IŞIK GÖNÜL İ., HELVACI Ö., DERİCİ Ü.

20. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, Turkey, 9 - 13 May 2018

Radiokontrast nefrotoksisitesinde dexpantenolün rolü

DERİCİ Ü., dumludağ b., sütçüoğlu O., HELVACI Ö., PAŞAOĞLU Ö. T., IŞIK GÖNÜL İ., et al.

20. ulusal hipertansiyon ve böbrek hastalıkları kongresi, Turkey, 9 - 13 May 2018

BELIEFS AND ATTITUDES OF HEMODIALYSIS PATIENTS ON INFLUENZA VACCINATION

Helvaci O., SÜTCÜOĞLU O., KORUCU B., DİZBAY M., Arinsoy T., DERİCİ Ü.

55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), Copenhagen, Denmark, 24 - 27 May 2018, vol.33 Sustainable Development

Gazi Üniversitesi Hemodiyaliz Hastalarının Influenza Aşısı İle İlgili Görüş Ve Tutumları

HELVACI Ö., SUTCUOGLU O., DERİCİ Ü., ARINSOY S. T.

19. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, Turkey, 10 - 14 May 2017 Sustainable Development

Adrenal failure secondary to bilateral adrenal metastasis as a presenting feature of lung cancer a case report

SÜTÇÜOĞLU O., BOLAYIR B., YALÇIN M. M., SATIŞ H., EROĞLU ALTINOVA A., AKTÜRK M. Y., et al.

18th European Congress of Endocrinology, Munich, 28 - 31 May 2016 Sustainable Development

Adrenal failure secondary to bilateral adrenal metastasis as a presenting feature of lun cancer a case report

sütçüoğlu O., BOLAYIR B., YALÇIN M. M., SATIŞ H., EROĞLU ALTINOVA A., AKTÜRK M. Y., et al.

ECE, 28 - 31 May 2016 Sustainable Development

Metrics

Publication

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

116

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citiation (TrDizin)

H-Index (TrDizin)

Project

Open Access

UN Sustainable Development Goals

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

Books & Book Chapters

Metrics

Publication

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citiation (TrDizin)

H-Index (TrDizin)

Project

Open Access